Generate a tailored SOP for Dr. Iwan De Esch. Improve your application with a focused, well-structured draft.
Professor Iwan de Esch is a prominent figure in Drug Design and Synthesis at the Vrije Universiteit Amsterdam, serving as the head of the Department of Chemistry & Pharmaceutical Sciences. His career is distinguished by his contributions to the field of Medicinal Chemistry, particularly in the application of Computer-Aided Drug Design (CADD). With a robust foundation in Organic Chemistry from Radboud University Nijmegen followed by a PhD at VU University, he advanced his expertise at the University of Cambridge, focusing on drug design and molecular interactions. He is known for his innovative work in Fragment-Based Drug Design (FBDD), developing efficient approaches to identify and optimize drug candidates targeting GPCRs, kinases, and other molecular targets. His research efforts have been instrumental in establishing several biotech spin-offs and he actively participates in educational programs designed to bridge the gap between science and industry. Notably, he has received prestigious research grants and awards, including the Galenus Research Prize for his work in fragment-based drug discovery. A committed advocate for scientific valorization, Prof. de Esch's contributions extend to enhancing the integration of scientific knowledge in business and innovation sectors, solidifying his role as a leader in both academia and the pharmaceutical industry.
Vrije Universiteit Amsterdam • Amsterdam
Leading research on drug design and synthesis, focusing on the development of new medicinal compounds.
De Novo Pharmaceuticals Ltd. •
Co-founded a biotech company specializing in drug discovery.
IOTA Pharmaceuticals Ltd. •
Co-founded a biotech firm focused on pharmaceutical innovations.
Griffin Discoveries B.V. •
Established a company aimed at advancing drug development technologies.
Administered under the Department of Clinical Psychology for Master's in Clinical and Developmental Psychopathology.